Purchases and Sales Made in Q2 2022 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q2 2022. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
838New |
$1.3K - $1.94K
|
838
$436
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-6- 0.15% |
$9.3 - $13.9
|
4.05K
$2.1K
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-100- 0.5% |
$155 - $232
|
19.9K
$10.3K
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-100- 0.5% |
$155 - $232
|
19.9K
$10.3K
|
|
|
Aug 12, 2022
Q2 2022
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-3.51K- 9.54% |
$5.44K - $8.15K
|
33.3K
$17.3K
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-3.75K- 21.28% |
$5.81K - $8.7K
|
13.9K
$7.21K
|